FDA Inspection 1028803 — LifeSource-Upper Midwest OPO

LifeSource-Upper Midwest OPO — FEI 3000718539

The FDA completed an inspection of LifeSource-Upper Midwest OPO on September 20, 2017 in Minneapolis, MN. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
September 20, 2017
Fiscal Year
2017
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Minneapolis, MN (United States)